Residency · Galveston, TX
Sponsored by University of Texas Medical Branch Hospitals
Proton versus photon radiotherapy for patients with oropharyngeal cancer in the USA: a multicentre, randomised, open-label, non-inferiority phase 3 trial.
Lancet (London, England) · 2026 · 35 citations · Brandon Gunn, Upendra Parvathaneni, Lauren Mayo
Surgery After BRAF-Directed Therapy Is Associated with Improved Survival in BRAFV600E Mutant Anaplastic Thyroid Cancer: A Single-Center Retrospective Cohort Study.
Thyroid : official journal of the American Thyroid Association · 2023 · 88 citations · Brandon Gunn
Anti-Programmed Death Ligand 1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma: A Nonrandomized Clinical Trial.
JAMA oncology · 2024 · 65 citations · Brandon Gunn
Artificial intelligence applications in prostate cancer.
Prostate cancer and prostatic diseases · 2024 · 52 citations · Raed Zuhour
Knowledge-based planning for fully automated radiation therapy treatment planning of 10 different cancer sites.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology · 2025 · 23 citations · Lauren Mayo
Continuous Androgen Deprivation Therapy with or Without Metastasis-directed Therapy for Oligometastatic Prostate Cancer: The Multicenter Phase 2 Randomized EXTEND Trial.
European urology · 2025 · 26 citations · Lauren Mayo
Initial Management of BRAF V600E-Variant Anaplastic Thyroid Cancer: The FAST Multidisciplinary Group Consensus Statement.
JAMA oncology · 2024 · 35 citations · Brandon Gunn
Impact of Somatic Mutations on Survival Outcomes in Patients With Anaplastic Thyroid Carcinoma.
JCO precision oncology · 2022 · 64 citations · Brandon Gunn